GlassScriptPhysician profile
Stephanie E Hughes
NPI 1083832281
$11,451.19
in general payments reported to CMS, 2019-2025
34 companies · $2,235 in 2025
The $2,235 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $648 · 2020: $455 · 2021: $625 · 2022: $1,590 · 2023: $2,954 · 2024: $2,944 · 2025: $2,235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,330 · Food and Beverage: $3,721 · Education: $82.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,329.97 |
| Food and Beverage | $3,721.38 |
| Education | $82.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,060.50 | 2020-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $2,022.59 | 2019-2025 | Axonics, Advantage System, Rezum Generator |
| Coloplast Corp | $1,925.84 | 2020-2025 | Altis |
| Astellas Pharma US INC | $973.80 | 2019-2025 | Xtandi |
| Medtronic, INC. | $635.69 | 2022 | |
| Sumitomo Pharma America, INC. | $356.86 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $206.71 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.88 | 2019-2023 | |
| Antares Pharma, INC. | $121.40 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Progenics Pharmaceuticals, INC. | $109.07 | 2021-2024 | Pylarify |
| Photocure INC | $89.22 | 2021-2025 | Cysview |
| Janssen Biotech, INC. | $84.17 | 2021-2025 | Erleada |
| C. R. Bard, INC. & Subsidiaries | $70.50 | 2020 | |
| Ethicon US, LLC | $67.31 | 2024 | Vistaseal |
| Laborie Medical Technologies Corp. | $59.23 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hollister Incorporated | $48.83 | 2021-2023 | Infyna Chic |
| Merck Sharp & Dohme LLC | $46.24 | 2022-2023 | Lynparza, Keytruda |
| Medtronic USA, INC. | $44.00 | 2019-2020 | |
| Halozyme INC | $42.01 | 2023 | |
| Allergan, INC. | $41.19 | 2020-2021 | |
| Abbvie INC. | $35.11 | 2022-2024 | |
| Siemens Medical Solutions USA, INC. | $32.08 | 2025 | Cios Alpha |
| Cook Medical LLC | $24.25 | 2023 | Cook |
| Accord Healthcare, INC. | $24.15 | 2024 | |
| Urovant Sciences INC | $23.93 | 2022 | |
| Procept Biorobotics Corporation | $21.20 | 2024 | Aquabeam System |
| Karl Storz Endoscopy-America | $20.15 | 2021 | |
| Olympus America INC. | $19.64 | 2024 | Itind System |
| Clarus Therapeutics INC. | $18.57 | 2021 | |
| Acerus Pharmaceuticals Corporation | $18.30 | 2021 | |
| Blue Earth Diagnostics | $18.00 | 2020 | |
| Baxter Healthcare | $16.35 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $16.14 | 2020 | |
| Endo Pharmaceuticals INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.